Autopsy report · NCT00804973

Study in Participants With Acute Migraines Headaches

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Due to efficacy results of interim analysis”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 6 months before it stopped.
120 participants enrolled.
Results were posted on the registry 11 years after it ended.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Eli Lilly and Company
Sponsor type: Industry
Conditions: Migraine Headache
Interventions: LY2590443; Placebo injection; Sumatriptan; Placebo capsule
Participants: 120
Sites: 19
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.